Senate Bill 4338
117th Congress(2021-2022)
Increasing Transparency in Generic Drug Applications Act
Introduced
Introduced in Senate on May 26, 2022
Origin Chamber
Senate
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
4338
Congress
117
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
No Senate votes have been held for this bill.
Summary
Increasing Transparency in Generic Drug Applications Act
This bill requires the Food and Drug Administration to inform generic drug applicants, upon request or during review, whether the drug is qualitatively and quantitatively the same as the listed brand-name drug (and if not, the reasons why).
May 26, 2022
05/26/2022
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
05/26/2022
Introduced in Senate
Public Record
Record Updated
Oct 11, 2023 7:30:36 PM